We read with great interest the article “Vessel Wall Enhancement in Unruptured Intracranial Aneurysms: An Indicator for Higher Risk of Rupture? High-Resolution MR Imaging and Correlated Histologic Findings,” published in the American Journal of Neuroradiology by Larsen et al.1 The authors found that wall enhancement in vessel wall MR imaging is associated with inflammatory cell invasion, neovascularization, and the presence of vasa vasorum, factors that provide valuable information for unruptured aneurysm risk stratification.1 Previous studies have suggested that aneurysm wall inflammation may precede, rather than result from, rupture. In as much as inflammation affects aneurysm growth and rupture, vessel wall enhancement may be a marker of rupture risk.2
However, we would like to discuss the clinical importance of the presence of aneurysm wall enhancement, detected by high-resolution MR imaging after treatment. We present the case of a 68-year-old woman with an unruptured anterior cerebral artery aneurysm treated with a flow diverter. Follow-up 3T MR angiography 1 month after flow-diverter placement showed magnetic susceptibility artifacts in the A1 portion of the right anterior cerebral artery, secondary to the flow diverter. The aneurysm, which measured 1.7 × 1.5 cm, had a T1-hyperintense signal within it due to thrombosis or slow flow induced by the treatment. Subtraction of the precontrast from the postcontrast enhanced vessel wall images revealed a thin rim of enhancement around the aneurysm wall, without edema in the surrounding parenchyma (Figure). The patient was asymptomatic at the time of the examination and is being monitored as an outpatient.
A thin rim of circumferential contrast enhancement around a treated aneurysm is commonly seen in contrast-enhanced TOF-MR angiography following treatment and should be an expected finding. This contrast enhancement is thought to be attributed to a combination of organized peripherally distributed intra-aneurysmal thrombosis, vasa vasorum within the adventitial layer of the aneurysm wall, and/or growth of vascularized tissue into an implanted coil mass or flow diverter due to inflammation or healing.3
Guan et al4 described 3 patients with intracranial aneurysms treated with flow diversion. Post treatment vessel wall high-resolution MR imaging to evaluate aneurysm obliteration revealed intra-aneurysm thrombus development, reduced aneurysm filling, and vessel wall enhancement of the aneurysm sac in all 3 patients. Although the authors did not discuss the significance of the wall enhancement detected by vessel wall imaging, all 3 patients were clinically well and in outpatient follow-up, like the case presented here. In such post treatment scenarios, vessel wall enhancement detected by high-resolution vessel wall MR imaging may be of no clinical significance and not a sign of elevated rupture risk, though this technique is more sensitive to inflammatory changes, atherosclerotic plaques, arterial dissection, and other causes of intracranial arterial narrowing than TOF-MR angiography.2
Hence, whereas vessel wall enhancement of nontreated intracranial aneurysms seen in high-resolution vessel wall imaging may be a marker of rupture risk,1,2 wall enhancement of a treated aneurysm may not necessarily be pathologic, though there is a lack of studies addressing the utility of vessel wall imaging in treated aneurysms in the literature.
References
- 1.
- 2.
- 3.
- 4.
- © 2018 by American Journal of Neuroradiology